Clinical meetings

← vista completa

Published on June 1, 2010 | http://doi.org/10.5867/medwave.2010.06.4592

Current topics in nuclear medicine for the internist

Tópicos de actualidad en medicina nuclear para el médico internista

Teresa Massardo

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Teresa Massardo

Sección Medicina Nuclear, Departamento de Medicina, Hospital Clínico Universidad de Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Massardo T. Current topics in nuclear medicine for the internist. Medwave 2010;10(06):e4592 doi: 10.5867/medwave.2010.06.4592

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/06/2010

Index

Metrics

Not available at the moment.

Notes

References

  1. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107(1):149-58. | CrossRef | PubMed
  2. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).Circulation 2003;108(11):1404-18. | CrossRef | PubMed
  3. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Huurman A, et al. Risk stratification of patients with angina pectoris by stress 99mTc-tetrofosmin myocardial perfusion imaging. J Nucl Med 2005;46(12):2003-8. | PubMed
  4. Sorajja P, Chareonthaitawee P, Rajagopalan N, Miller TD, Frye RL, Hodge DO, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation 2005;112(9 Suppl):I311-6. | PubMed
  5. Berman DS, Rozanski A, Rana JS, Shaw LJ, Wong ND, Min JK. Screening for coronary artery disease in diabetic patients: a commentary. J Nucl Cardiol 2009;16(6):851-4. Epub 2009 Aug 19. | CrossRef | PubMed
  6. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954-61. | CrossRef | PubMed
  7. Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. Diabetes Care 2007;30(11):2892-8. Epub 2007 Aug 6. | CrossRef | PubMed
  8. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Poldermans D. Differential prognostic significance of peri-infarction versus remote myocardial ischemia on stress technetium-99m sestamibi tomography in patients with healed myocardial infarction. Am J Cardiol2004;94(3):289-93. | CrossRef | PubMed
  9. Kassis AI, Adelstein SJ. Radiobiologic principles in radionuclide therapy. J Nucl Med 2005;46 Suppl 1:4S-12S. | PubMed
  10. Kaltsas GA, Papadogias D, Makras P, Grossman AB. Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues. Endocr Relat Cancer 2005;12(4):683-99. | PubMed
  11. Forrer F, Uusijärvi H, Storch D, Maecke HR, Mueller-Brand J. Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC. J Nucl Med 2005;46(8):1310-6. | PubMed
  12. Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, et al. Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 2008;26(13):2124-30. | CrossRef | PubMed
  13. Cilley J, Winter JN. Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas. Haematologica 2006;91(1):114-20. | PubMed
  14. Conti PS, White C, Pieslor P, Molina A, Aussie J, Foster P. The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. J Nucl Med 2005;46(11):1812-8. | PubMed
  15. Juweid ME. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med 2002;43(11):1507-29. | PubMed
  16. Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005;16(12):1627-39. | PubMed
  17. Salem R. Ytrium-90 for the treatment of primary and secondary hepatic malignancies: early results and future directions. SNM Annual Meeting handouts, Toronto 2005.